Fiji vs Kazakhstan: Cause of death, by non-communicable diseases, ages 5-14
Fiji
38.5%
in 2021
Kazakhstan
38.6%
in 2021
Fiji rank
89th
Kazakhstan rank
87th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Fiji
- Kazakhstan
How they compare
Kazakhstan currently reports 38.6% against 38.5% in Fiji, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Fiji ahead.
Fiji ranks 89th and Kazakhstan ranks 87th of 185 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 33.1% | 5.8% | Fiji |
| 2010s | 42.1% | 38.5% | 3.7% | Fiji |
| 2020s | 41.5% | 39.9% | 1.6% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Fiji or Kazakhstan?
- Kazakhstan, at 38.6% against 38.5% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Fiji and Kazakhstan?
- 0.1%, with Kazakhstan ahead.
- How many years of comparable data are there for Fiji and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Kazakhstan rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Fiji ranks 89th and Kazakhstan ranks 87th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.